ATTENTION All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY
Background: BPC-157 has never been approved by the FDA for any human use
In mouse models of insulin resistance, it significantly inhibits NNMT activity in liver and muscle, reduces NAM methylation, increases intracellular NAD+, activates the SIRT1 pathway, promotes phosphorylation of insulin receptor substrate 1 (IRS1), enhances insulin signaling, improves insulin sensitivity, and increases glucose uptake and utilization
(5) A B12 deficiency results in a functional folate deficiency, as folate cant be converted to methyltetrahydrofolate
Primary research: Insulin sensitivity, exercise capacity, metabolic regulation Mechanism: Activates AMPK pathway, regulates folate-methionine metabolism, and modulates nuclear gene expression from the mitochondria Regulatory status: Not FDA-approved